Biognosys Presenting Data on its TrueDiscovery and TrueTarget Proteomics Platforms at the AACR Annual Meeting 2022
Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical settings Biognosys, a leader in next-generation